IQV
NYSEIQVIA HOLDINGS INC.
Industrials · Services-Commercial Physical & Biological Research
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$13.9B
2021
$14.4B
2022
$15.0B
2023
$15.4B
2024
$16.3B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$16.3B
Net Income$1.4B
Gross Profit—
Oper Income$2.2B
EPS (dil)$7.84
Rev/sh$97.72
FCF/sh—
Book/sh$39.72
Gross M—
Oper M13.4%
Profit M8.3%
FCF M—
ROE20.5%
ROA4.5%
ROIC9.0%
R&D/Rev0.0%
Rev Y/Y5.9%
Rev 3Y CAGR4.2%
EPS Y/Y4.7%
EPS 3Y CAGR11.1%
FCF 3Y CAGR—
Payout42%
Div/sh—
Shs Chg Y/Y-5.4%
Current Ratio0.75
Quick Ratio—
Debt/Eq2.37
Int Coverage3.0×
Net Debt$13.7B
Total Debt$15.7B
Cash & Eq$2.0B
Total Assets$29.9B
Oper CF$2.7B
Capex—
Free CF—
Buybacks$1.2B
Equity$6.6B
Liabilities$23.3B
Shs Outstand0.17B
SectorIndustrials
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $13.9B | $14.4B | $15.0B | $15.4B | $16.3B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.4B | $1.8B | $2.0B | $2.2B | $2.2B |
| Net Income | $971.0M | $1.1B | $1.4B | $1.4B | $1.4B |
| Diluted EPS | $4.95 | $5.72 | $7.29 | $7.49 | $7.84 |
| Operating Cash Flow | $2.9B | $2.3B | $2.1B | $2.7B | $2.7B |
| Free Cash Flow | — | — | — | — | — |
COMMUNITY · $IQV0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.